Edition:
United States

Melinta Therapeutics, Inc. (MLNT.OQ)

MLNT.OQ on NASDAQ Stock Exchange Global Select Market

7.45USD
4:00pm EDT
Change (% chg)

$-0.50 (-6.29%)
Prev Close
$7.95
Open
$7.95
Day's High
$7.95
Day's Low
$7.28
Volume
65,264
Avg. Vol
86,320
52-wk High
$24.25
52-wk Low
$5.20

Select another date:

Wed, May 23 2018

BRIEF-Melinta Therapeutics Prices Public Offering Of 22.0 Mln Shares At $5/Share

* MELINTA THERAPEUTICS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK

BRIEF-Melinta Therapeutics Announces Proposed Offering Of Common Stock

* MELINTA THERAPEUTICS ANNOUNCES PROPOSED OFFERING OF COMMON STOCK

BRIEF-Melinta Therapeutics Q1 Loss Per Share $0.95

* MELINTA THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

BRIEF-Melinta Therapeutics Q4 Loss Per Share $1.48

* MELINTA THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

BRIEF-Melinta Therapeutics Partner, Menarini Group, Submits Marketing Authorization Application For Delafloxacin In Europe

* MELINTA THERAPEUTICS PARTNER, MENARINI GROUP, SUBMITS MARKETING AUTHORIZATION APPLICATION FOR DELAFLOXACIN IN EUROPE

BRIEF-Melinta Therapeutics Launches Antibiotic Baxdela In U.S.

* MELINTA THERAPEUTICS LAUNCHES ANTIBIOTIC BAXDELA™ (DELAFLOXACIN) IN THE UNITED STATES Source text for Eikon: Further company coverage:

BRIEF-Melinta Therapeutics Files For Mixed Shelf Offering Of Upto $150 Million

* MELINTA THERAPEUTICS INC FILES FOR MIXED SHELF OFFERING OF UPTO $150 MILLION - SEC FILING Source text - http://bit.ly/2DSYZpm Further company coverage:

BRIEF-Melinta Therapeutics Says ‍Partner Commenced New Program For Topical Formulation Of Radezolid, In Preparation For Submitting IND Application To FDA

* MELINTA THERAPEUTICS - ‍PARTNER COMMENCED NEW PROGRAM FOR A TOPICAL FORMULATION OF RADEZOLID, IN PREPARATION FOR SUBMITTING AN IND APPLICATION TO FDA Source text for Eikon: Further company coverage:

BRIEF-Melinta Therapeutics Files For Resale Of Up To 6.9 Mln Shares By Selling Stockholders

* MELINTA THERAPEUTICS INC FILES FOR RESALE OF UP TO 6.9 MILLION SHARES OF CO'S COMMON STOCK BY SELLING STOCKHOLDERS - SEC FILING‍​ Source text: (http://bit.ly/2EqugN6) Further company coverage:

BRIEF-Melinta Therapeutics Files For Resale Of Up To 3.3 Mln Shares By Selling Stockholder

* MELINTA THERAPEUTICS INC FILES FOR RESALE OF UP TO 3.3 MILLION SHARES OF CO'S COMMON STOCK BY SELLING STOCKHOLDER - SEC FILING Source text for Eikon: (http://bit.ly/2CO48LP) Further company coverage:

Select another date: